Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. - Wikidata - wikimedia - TriplyDB

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.

http://www.wikidata.org/entity/Q34816422

about

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer Clinical outcome prediction by microRNAs in human cancer: a systematic review miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity MicroRNA-210: a unique and pleiotropic hypoxamir Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1)MiR-210--micromanager of the hypoxia pathway miRNAs in human cancer An integrated approach for experimental target identification of hypoxia-induced miR-210 Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer Clinical Potential of microRNA-7 in Cancer MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer HypoxamiRs and cancer: from biology to targeted therapy Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer MicroRNAs: promising new antiangiogenic targets in cancer Breast cancer epigenetics: from DNA methylation to microRNAs ApoptomiRs of Breast Cancer: Basics to Clinics Mechanisms and role of microRNA deregulation in cancer onset and progression Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway miR-210: More than a silent player in hypoxia miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors Detection of cancer with serum miRNAs on an oligonucleotide microarray.The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas Prioritization of disease microRNAs through a human phenome-microRNAome network The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer.miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2.A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3.Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype MicroRNA sequence and expression analysis in breast tumors by deep sequencing.Identification and pathway analysis of microRNAs with no previous involvement in breast cancer.Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status

P2860

Q21134914-52A47503-6A09-4AC8-9731-57AB51296515 Q21245710-19C55974-E9F4-4CB0-AFE0-E88121881E62 Q24289183-E3D51F1B-16EA-4605-8A03-ECB69D8EA52B Q24595376-4386E55B-7D9A-4521-B592-ABF7F3FCD265 Q24601095-2D07E0BD-4059-4AFA-B64E-7B0142D13418 Q24607462-DB02D9AD-06E5-4E01-B7E7-CE7A8C3ED359 Q24617676-65220DE5-1F15-4365-9CE4-356378607FB5 Q24628401-806E7C7B-08A8-44C7-86F0-03897025C584 Q24628889-872E9923-54A0-4255-9C7B-88ABE847BABD Q24646947-7C80CA8F-A0AA-4AAA-8091-2F3DFA9149A3 Q24651016-7BB4E686-B81C-4665-8E74-077DDF9073DC Q26748881-9619CF1D-2789-492A-8FFC-C7FF6796B048 Q26775086-33D0D908-3534-473E-A6BC-E3C914820615 Q26797306-0229659A-68CC-46DE-A422-38386F384ABF Q26801108-E17BF0BB-6104-43CE-8753-F699DEE3A679 Q26863298-DD747FBB-A49A-4555-9D71-1B3AE9582A0A Q27011221-CDF24D28-6B94-44C2-BBCA-2D11C2C302AA Q27016123-3C26E618-193E-4BB1-A0E0-C62BEE1181CD Q27027998-ECD8BEA0-78C4-474A-B216-027510DAF677 Q27694164-A2DE3688-EE9B-431E-B9DF-D0BBD4ADDBAD Q28072414-B27642E2-EA7A-4816-8358-6396315A4A21 Q28109709-2DB9069D-3156-46D0-87CA-D198557C841C Q28259224-E7F33346-6F9E-4CF0-8A92-3D3B8A23467D Q28275238-EB951529-458F-41BB-B795-9E01FCC60D4C Q28306244-E26E81BF-F0E5-4F6D-BE6D-5DCA846BB77F Q28742532-42878677-D12C-45B5-BD76-2C63B009A441 Q33481633-F287CDCA-9827-4CC4-AF32-1EC77E6FAB2F Q33538051-4951488D-90D7-4E15-9F70-B33819AC9200 Q33593578-A5048CEE-D8BC-486F-A9F9-0D77EF6A6C92 Q33613310-C3B0F939-F5FC-4AC4-A6A1-920E89C4C27E Q33671054-FC4D5ACF-1073-47CF-BD55-1C0361CADDA9 Q33779774-9EB54CD7-6DE6-43C0-B14C-8815050AE9A0 Q33837404-EB257894-9871-490F-97A4-E246404628E3 Q34031000-34048B8F-EC83-4464-A67F-812E70254544 Q34129423-F02DC135-77E2-48B5-8270-E34D049239AF Q34185623-6B0AC1AB-A924-4F4A-B365-740AD14B3049 Q34206037-7A76B703-3842-41C9-A5BD-3062AA9226FF Q34281856-E3DF4F03-3355-44AE-AA8A-DE4D09B0EB95 Q34306416-C22B70F2-6253-4C80-9EC8-874A6EEEBE92 Q34314082-3BA8A913-40F2-4D04-AA17-4FEAA7E4D1AA

P2860

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.

http://www.wikidata.org/entity/Q34816422

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Four miRNAs associated with ag ...... -positive human breast cancer.

@ast

Four miRNAs associated with ag ...... -positive human breast cancer.

@en

Four miRNAs associated with ag ...... -positive human breast cancer.

@nl

type

label

Four miRNAs associated with ag ...... -positive human breast cancer.

@ast

Four miRNAs associated with ag ...... -positive human breast cancer.

@en

Four miRNAs associated with ag ...... -positive human breast cancer.

@nl

prefLabel

Four miRNAs associated with ag ...... -positive human breast cancer.

@ast

Four miRNAs associated with ag ...... -positive human breast cancer.

@en

Four miRNAs associated with ag ...... -positive human breast cancer.

@nl

P1433

Q34816422-2FDDE712-F8DD-424C-A81F-B1A499A04B98

P1476

Q34816422-40A79FFA-2720-4EBB-B4AF-B75B0C4A2110

P2093

Q34816422-3ED57549-4332-4B83-A2AE-4BDD6B7A785E

Q34816422-4ACA208F-97D3-4750-A24D-4050F6856A0E

Q34816422-5052B552-3660-4EA6-9680-F68C77107DBD

Q34816422-6543C3D5-2E2E-4D07-BA1F-DD90820B941F

Q34816422-677B71D5-4151-4511-85D8-8959A927C0EA

Q34816422-69EAC270-1273-4B36-8055-8A1E2D53A581

Q34816422-C85ED7D3-C3BE-4736-8014-9F8AFB763154

Q34816422-E065BEC4-1AC3-4931-A9EA-A5AF0E8A6C6C

Q34816422-EFCA09E4-7FAE-411A-AA4D-222989EFF5AE

P2860

Q34816422-071A381B-747B-4828-B32F-30D6AEF52B5D

Q34816422-1324D843-9219-494E-B567-3A05B0CF7045

Q34816422-182CCA21-8494-4CB1-9022-B71604BC8540

Q34816422-1FFA5F75-5E56-476A-98EC-65ACE97ABEC0

Q34816422-241660E3-562F-40B2-A2F7-FB562BA35ADB

Q34816422-2E6BC050-F02E-4557-9A1E-92E5CE648A05

Q34816422-35A8419C-51CC-4D9C-B343-CE5734C72EEA

Q34816422-3C89D8DB-071B-46FB-97E4-C483B2DE308E

Q34816422-48275254-64D9-4AE5-8BA0-086DBB2ABF03

Q34816422-4F0E8211-7B18-4C22-B3E3-2F361521C37C

P304

Q34816422-CB23137B-3DEB-4E42-8868-04F837E4F858

P31

Q34816422-5B807622-EE51-4D85-9436-286FC98A6E1E

P356

Q34816422-EF522E50-6414-466A-98FA-EB6BF29C9A31

P407

Q34816422-6D59E1B5-9D5E-48B6-B73C-EE221F1912EC

P433

Q34816422-D3A3E2D4-67F1-4AD2-BF2A-D74F0AA276CF

P478

Q34816422-3C11F7FC-FA67-49BC-9226-A7390E54753B

P577

Q34816422-E56F6D78-5344-49BE-B800-16DDAD6BF6C0

P5875

Q34816422-8A8B39CA-1F2C-4C14-AF52-EBEB98AE3502

P698

Q34816422-9E776D56-607C-42C8-889F-FE2F97DCCB17

P921

Q34816422-F4A4DF14-08B6-4FF1-B94A-5F9C03C2CF90

P932

Q34816422-6BD5B3A8-C43B-43EF-A726-8B50869B9FF7

P356

PNAS.0803304105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Four miRNAs associated with ag ...... -positive human breast cancer.

@en

P2093

Anieta M Sieuwerts

http://www.w3.org/2001/XMLSchema#string

Antonius W M Boersma

http://www.w3.org/2001/XMLSchema#string

Erik A C Wiemer

http://www.w3.org/2001/XMLSchema#string

Jan G M Klijn

http://www.w3.org/2001/XMLSchema#string

John A Foekens

http://www.w3.org/2001/XMLSchema#string

John W M Martens

http://www.w3.org/2001/XMLSchema#string

Marcel Smid

http://www.w3.org/2001/XMLSchema#string

Maxime P Look

http://www.w3.org/2001/XMLSchema#string

Vanja de Weerd

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

A microRNA expression signature of human solid tumors defines cancer gene targets

microRNAs exhibit high frequency genomic alterations in human cancer

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

A microRNA signature of hypoxia

Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

MicroRNA gene expression deregulation in human breast cancer

Gene expression profiling predicts clinical outcome of breast cancer

P304

13021-13026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0803304105

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23222287

http://www.w3.org/2001/XMLSchema#string

P698

18755890

http://www.w3.org/2001/XMLSchema#string

P921

P932

2529088

http://www.w3.org/2001/XMLSchema#string